Key facts
- This page summarizes Manner Carrie Eglinton's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 28 Feb 2022, 18:32.
Manner Carrie Eglinton - 24 Feb 2022 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)
- Reporting relationship
- SVP, Advanced Diagnostics
- Issuer ticker
- DGX
- Reported as of
- 24 Feb 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 28 Feb 2022, 18:32:56 UTC
- Prior SEC filing
- 25 Feb 2022
- Next SEC filing
- 09 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ William J. O'Shaughnessy, Jr., as attorney-in-fact for Carrie Eglinton Manner
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Manner Carrie Eglinton filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 28 Feb 2022.
Change
- Previous filing in this sequence was filed on 25 Feb 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DGX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +3,915
- Change %
- +14%
- Price
- $0.000000
- Shares after
- 32,346
- Date
- 24 Feb 2022
- Ownership
- Direct
- Footnotes
- F1
DGX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +7,830
- Change %
- +24%
- Price
- $0.000000
- Shares after
- 40,176
- Date
- 24 Feb 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DGX
transaction
Derivative
Non-Qualifed Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +19,009
- Change %
- Price
- $0.000000
- Shares after
- 19,009
- Date
- 24 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 19,009
- Exercise price
- $127.72
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents an award of restricted share units.
Footnote F2
The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.